The biology and management of non-small cell lung cancer
RS Herbst, D Morgensztern, C Boshoff - Nature, 2018 - nature.com
… in the treatment of non-small cell lung cancer (NSCLC) have … advancing early detection and
multimodal care. The use of small … However, the overall cure and survival rates for NSCLC …
multimodal care. The use of small … However, the overall cure and survival rates for NSCLC …
Non–small cell lung cancer
… The WHO divides lung cancer into 2 major classes based on its biology, therapy, and
prognosis: NSCLC and small cell lung cancer (SCLC; see the NCCN Guidelines for Small …
prognosis: NSCLC and small cell lung cancer (SCLC; see the NCCN Guidelines for Small …
Non-small-cell lung cancer
C Gridelli, A Rossi, DP Carbone, J Guarize… - Nature reviews Disease …, 2015 - nature.com
… Drugs approved by the FDA for the treatment of non-small-cell lung cancer. ALK, anaplastic
lymphoma kinase; EGFR, epidermal growth factor receptor; TKIs, tyrosine kinase inhibitors; …
lymphoma kinase; EGFR, epidermal growth factor receptor; TKIs, tyrosine kinase inhibitors; …
[HTML][HTML] Non-small cell lung cancer: current treatment and future advances
C Zappa, SA Mousa - Translational lung cancer research, 2016 - ncbi.nlm.nih.gov
… Non-small cell lung cancer (NSCLC) accounts for the majority of all … There are two main
subtypes of lung cancer, small-cell lung carcinoma and non-small-cell lung carcinoma (NSCLC), …
subtypes of lung cancer, small-cell lung carcinoma and non-small-cell lung carcinoma (NSCLC), …
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship
JR Molina, P Yang, SD Cassivi, SE Schild… - Mayo clinic …, 2008 - Elsevier
… cancer cases in the United States. After the initial diagnosis, accurate staging of non-small
cell lung cancer using … is crucial for determining appropriate therapy. When feasible, surgical …
cell lung cancer using … is crucial for determining appropriate therapy. When feasible, surgical …
Non-small-cell lung cancer
… lung cancer there have been advances in many aspects of the classification, diagnosis, and
treatment of non-small-cell lung cancer … and more effective treatment of the disease, and the …
treatment of non-small-cell lung cancer … and more effective treatment of the disease, and the …
Toward personalized treatment approaches for non-small-cell lung cancer
M Wang, RS Herbst, C Boshoff - Nature medicine, 2021 - nature.com
… , lung cancer is the most common cause of cancer-related deaths. Molecular targeted therapies
and immunotherapies for non-small-cell lung cancer … to current treatments and eventually …
and immunotherapies for non-small-cell lung cancer … to current treatments and eventually …
[HTML][HTML] Treatment of non-small cell lung cancer (NSCLC)
K Zarogoulidis, P Zarogoulidis, K Darwiche… - Journal of thoracic …, 2013 - ncbi.nlm.nih.gov
… of care for fit stage I non-small cell lung cancer (NSCLC) patients. Adjuvant treatment should
… In advanced stage IIIB/IV or inoperable NSCLC pts, a multidisciplinary treatment should be …
… In advanced stage IIIB/IV or inoperable NSCLC pts, a multidisciplinary treatment should be …
Management of non-small-cell lung cancer: recent developments
… therapy, irrespective of histological subtype, without any option for further lines of treatment.
… , docetaxel, and paclitaxel, treatment of non-small-cell lung cancer changed, and overall …
… , docetaxel, and paclitaxel, treatment of non-small-cell lung cancer changed, and overall …
[HTML][HTML] Treatment of advanced non small cell lung cancer
MA Bareschino, C Schettino, A Rossi… - Journal of thoracic …, 2011 - ncbi.nlm.nih.gov
… Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death in the … ,
including squamous cell carcinoma, adenocarcinoma and large cell carcinoma, its represents …
including squamous cell carcinoma, adenocarcinoma and large cell carcinoma, its represents …
相关搜索
- non-small cell lung cancer treatment landscape
- non-small cell lung cancer treatment approaches
- non-small cell lung cancer targeted therapies
- non-small cell lung cancer practice guidelines
- non-small cell lung cancer risk factors
- patients with non-small cell lung cancer
- operable non-small cell lung cancer
- chemotherapy of non-small cell lung cancer
- non-small cell lung cancer stage
- completely resected non-small cell lung cancer
- heterogeneous set non-small cell lung cancers
- metastatic non-small cell lung cancer
- egfr mutant non-small cell lung cancer
- early diagnostics non-small cell lung carcinoma
- non-small cell lung cancer driver mutations
- non-small cell lung cancer growth factor